Conference Coverage
Conference Coverage
Fremanezumab fails posttraumatic headache test
The anti-CGRP antibody provided no benefit, despite success in other headache types.
Conference Coverage
Nitroglycerine lends insight into migraine
Sometimes underappreciated method allows better study of premonitory symptoms.
Conference Coverage
Intranasal third-generation CGRP effective for acute migraine
Among patients taking zavegepant, more than 20% achieved pain freedom and 40% were relieved of their most bothersome symptom.
Conference Coverage
Cannabis for migraine strongly linked to rebound headache
Are patients using cannabis to treat medication overuse headache, or is cannabis contributing to the development of said headaches, or both?
Conference Coverage
Investigative gepant liver profile comparable with standard of care
The investigative oral chronic migraine therapy atogepant had 1-year side-effect and hepatic function profiles comparable with the standard of...
Conference Coverage
Rimegepant looks safe in migraine patients with cardiovascular risk
Multiple-use safety study shows similar frequency of adverse events regardless of cardiovascular risk.
Conference Coverage
Migraineurs not taking advantage of an ‘effective prophylactic’
Exercise is an underutilized resource in migraine management.
Conference Coverage
Chronic daily migraine from medication overuse: How worried should you be?
Medication overuse headache is ill-defined, but likely a problem for some.
Conference Coverage
A closer look at migraine aura
Accumulating evidence suggests that cortical spreading depression may underlie migraine aura.
Conference Coverage
Choroid plexuses may play a role in migraine
A study of blood–cerebrospinal fluid transport implicates choroid plexuses and reveals a novel migraine biomarker.